Cargando…

MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer

Cumulating evidence indicates that dysregulation of microRNAs (miRNAs) plays a central role in the initiation, progression, and drug resistance of cancer cells. However, the specific miRNAs contributing to drug resistance in ovarian cancer cells have not been fully elucidated. Aimed to identify pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiñones-Díaz, Blanca I., Reyes-González, Jeyshka M., Sánchez-Guzmán, Victoria, Conde-Del Moral, Isabel, Valiyeva, Fatma, Santiago-Sánchez, Ginette S., Vivas-Mejía, Pablo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774672/ https://www.ncbi.nlm.nih.gov/pubmed/33392094 http://dx.doi.org/10.3389/fonc.2020.602670

Ejemplares similares

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
por: Echevarría-Vargas, Ileabett M., et al.
Publicado: (2014)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2021)

3468 Predictive biomarkers of platinum-based chemotherapy response in Puerto Rican Hispanics with high-grade serous ovarian cancer.
por: Reyes-Gonzalez, Jeyshka M., et al.
Publicado: (2019)

Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer
por: Noriega-Rivera, Ricardo, et al.
Publicado: (2022)

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2020)

Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2020)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells
por: Báez-Vega, Perla M., et al.
Publicado: (2016)

Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
por: Zhang, Y., et al.
Publicado: (2017)

Role of Matrix Metalloproteinases in Angiogenesis and Cancer
por: Quintero-Fabián, Saray, et al.
Publicado: (2019)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Matrix Metalloproteinases as a Pleiotropic Biomarker in Medicine and Biology
por: Kurzepa, Jacek, et al.
Publicado: (2016)

Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer
por: Rasool, Mahmood, et al.
Publicado: (2016)

Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
por: Kicman, Aleksandra, et al.
Publicado: (2022)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010)

Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
por: Lozada-Delgado, Eunice L., et al.
Publicado: (2018)

Vitrification affects the expression of matrix metalloproteinases and their tissue inhibitors of mouse ovarian tissue
por: Asadzadeh, Reza, et al.
Publicado: (2016)

Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome
por: Wang, Shujie, et al.
Publicado: (2019)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2023)

Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma
por: Farias, Lucyana Conceição, et al.
Publicado: (2012)

Metalloproteinases in Ovarian Cancer
por: Carey, Preston, et al.
Publicado: (2021)

Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
por: Wang, Liping, et al.
Publicado: (2013)

Matrix Metalloproteinases in Cerebral Ischemia
por: Kim, Hahn Young, et al.
Publicado: (2006)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Matrix metalloproteinases in exercise and obesity
por: Jaoude, Jonathan, et al.
Publicado: (2016)

Matrix Metalloproteinases and Glaucoma Treatment
por: Weinreb, Robert N., et al.
Publicado: (2020)

Challenges in Matrix Metalloproteinases Inhibition
por: Laronha, Helena, et al.
Publicado: (2020)

Matrix Metalloproteinases in Health and Disease
por: Serra, Raffaele
Publicado: (2020)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_vfbckpg2eek112fin096diq6o1